Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial.

J Am Heart Assoc · 2021 · PMC8751847 · PMID 34658247

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0930

boldest claim

The sentences

reached borderline significanceP =0.058so close (0.05 < p ≤ 0.1)

Further, the interaction between the treatment groups and atherothrombosis/non‐atherothrombosis group reached borderline significance ( P =0.058); see Figure 3B .

also in 370 other papers

failed to reach significanceP =0.093so close (0.05 < p ≤ 0.1)

Nevertheless, the interaction failed to reach significance ( P =0.093).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.